QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)
QQQ   337.27 (+1.86%)
AAPL   175.05 (+1.37%)
MSFT   318.52 (+1.44%)
META   246.85 (+1.80%)
GOOGL   122.83 (+1.65%)
AMZN   118.15 (+2.29%)
TSLA   176.89 (+1.74%)
NVDA   316.78 (+4.97%)
NIO   7.82 (-2.62%)
BABA   85.77 (-5.41%)
AMD   107.93 (+4.03%)
T   16.55 (-0.66%)
F   11.64 (+1.22%)
MU   67.57 (+4.08%)
CGC   1.05 (+0.00%)
GE   104.01 (+0.52%)
DIS   93.76 (+1.07%)
AMC   5.07 (-0.59%)
PFE   36.48 (-0.73%)
PYPL   61.27 (-0.31%)
NFLX   371.29 (+9.22%)

Dawson James Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
NRx Pharmaceuticals stock logo
NRXP
NRx Pharmaceuticals
3/17/2023Reiterated byDawson JamesAnalyst J. KolbertBuyLow
GeoVax Labs stock logo
GOVX
GeoVax Labs
3/3/2023Initiated byDawson JamesBuy $4.00Low
Smith Micro Software stock logo
SMSI
Smith Micro Software
2/28/2023Target Lowered byDawson James$8.30 -> $3.50Low
Arcimoto stock logo
FUV
Arcimoto
2/15/2023Upgraded byDawson JamesAnalyst J. McilreeSell -> NeutralLow
Sorrento Therapeutics stock logo
SRNE
Sorrento Therapeutics
2/13/2023Downgraded byDawson JamesBuy -> NeutralN/A
Genprex stock logo
GNPX
Genprex
1/30/2023Initiated byDawson JamesBuy $3.00Low
Zomedica stock logo
ZOM
Zomedica
1/6/2023Initiated byDawson JamesAnalyst J. KolbertBuy $6.00N/A
Better Choice stock logo
BTTR
Better Choice
11/11/2022Target Lowered byDawson James$10.00 -> $4.00Low
BioCardia stock logo
BCDA
BioCardia
11/11/2022Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLow
Byrna Technologies stock logo
BYRN
Byrna Technologies
9/8/2022Target Lowered byDawson James$12.00 -> $9.50Low
Arcimoto stock logo
FUV
Arcimoto
9/6/2022Downgraded byDawson JamesAnalyst J. KolbertNeutral -> SellLow
ProPhase Labs stock logo
PRPH
ProPhase Labs
7/21/2022Downgraded byDawson JamesNeutral -> SellLow
Dyadic International stock logo
DYAI
Dyadic International
7/18/2022Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLow
Byrna Technologies stock logo
BYRN
Byrna Technologies
4/26/2022Initiated byDawson JamesBuy $12.00High
Arcimoto stock logo
FUV
Arcimoto
3/15/2022Initiated byDawson JamesNeutralMedium
Lineage Cell Therapeutics stock logo
LCTX
Lineage Cell Therapeutics
3/11/2022Reiterated byDawson JamesAnalyst Jason KolbertBuy $6.00N/A
Smith Micro Software stock logo
SMSI
Smith Micro Software
3/11/2022Target Lowered byDawson JamesBuy$11.40 -> $8.30High
Profire Energy stock logo
PFIE
Profire Energy
3/9/2022Target Raised byDawson James$1.65 -> $2.00Low
Know Labs stock logo
KNWN
Know Labs
2/8/2022Initiated byDawson JamesBuy $7.00High
22nd Century Group stock logo
XXII
22nd Century Group
1/6/2022Target Raised byDawson JamesAnalyst James McIlreeBuy -> Buy$7.00 -> $8.50N/A
Brainstorm Cell Therapeutics stock logo
BCLI
Brainstorm Cell Therapeutics
12/22/2021Reiterated byDawson JamesAnalyst J. KolbertNeutralMedium
Vuzix stock logo
VUZI
Vuzix
12/21/2021Initiated byDawson JamesBuy $15.00Medium
Genius Brands International stock logo
GNUS
Genius Brands International
12/15/2021Initiated byDawson JamesBuy $50.00High
Adamis Pharmaceuticals stock logo
ADMP
Adamis Pharmaceuticals
12/3/2021Reiterated byDawson JamesAnalyst J. KolbertNeutralHigh
ProPhase Labs stock logo
PRPH
ProPhase Labs
10/13/2021Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
Better Choice stock logo
BTTR
Better Choice
8/31/2021Initiated byDawson JamesBuyHigh
Profire Energy stock logo
PFIE
Profire Energy
8/5/2021Initiated byDawson JamesAnalyst James McIlreeBuy $1.65High
Smith Micro Software stock logo
SMSI
Smith Micro Software
8/5/2021Initiated byDawson JamesBuy $11.10High
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
6/21/2021Target Raised byDawson JamesBuy$19.00 -> $35.00Low
BioCardia stock logo
BCDA
BioCardia
4/22/2021Reiterated byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
BioCardia stock logo
BCDA
BioCardia
4/16/2021Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralHigh
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
2/25/2021Reiterated byDawson JamesAnalyst J. KolbertBuy $6.00Low
Fortress Biotech stock logo
FBIO
Fortress Biotech
2/17/2021Target Raised byDawson JamesBuy$16.00 -> $21.00Low
ProPhase Labs stock logo
PRPH
ProPhase Labs
1/20/2021Initiated byDawson JamesBuy $25.00High
Athersys stock logo
ATHX
Athersys
10/12/2020Reiterated byDawson JamesBuyLow
Lineage Cell Therapeutics stock logo
LCTX
Lineage Cell Therapeutics
10/12/2020Reiterated byDawson JamesBuy $6.00N/A
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
9/17/2020Reiterated byDawson JamesAnalyst J. KolbertBuyLow
Adamis Pharmaceuticals stock logo
ADMP
Adamis Pharmaceuticals
8/24/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
Daré Bioscience stock logo
DARE
Daré Bioscience
7/12/2020Reiterated byDawson JamesBuy $3.00High
Adamis Pharmaceuticals stock logo
ADMP
Adamis Pharmaceuticals
6/15/2020Upgraded byDawson JamesAnalyst Jason KolbertBuy $1.00Medium
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
6/8/2020Reiterated byDawson JamesBuy $16.00Medium
Sorrento Therapeutics stock logo
SRNE
Sorrento Therapeutics
5/26/2020Initiated byDawson JamesBuy -> Buy $24.00Low
Athersys stock logo
ATHX
Athersys
5/6/2020Reiterated byDawson JamesBuy $300.00Low
Cytosorbents stock logo
CTSO
Cytosorbents
3/9/2020Reiterated byDawson JamesBuy$15.00 -> $17.00High
Adamis Pharmaceuticals stock logo
ADMP
Adamis Pharmaceuticals
2/27/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralHigh
Dyadic International stock logo
DYAI
Dyadic International
2/26/2020Reiterated byDawson JamesAnalyst Jason KolbertBuyHigh
Mesoblast stock logo
MESO
Mesoblast
12/19/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $14.00Low
Dyadic International stock logo
DYAI
Dyadic International
10/16/2019Initiated byDawson JamesBuy $14.00Low
Emmaus Life Sciences stock logo
EMMA
Emmaus Life Sciences
9/24/2019Downgraded byDawson JamesBuy -> NeutralHigh
BioCardia stock logo
BCDA
BioCardia
9/17/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $24.00Low
BioCardia stock logo
BCDA
BioCardia
9/17/2019Reiterated byDawson JamesAnalyst J. KolbertBuyMedium
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
9/6/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $7.00N/A
Fortress Biotech stock logo
FBIO
Fortress Biotech
8/26/2019Initiated byDawson JamesBuy $19.00High
Athersys stock logo
ATHX
Athersys
8/26/2019Initiated byDawson JamesBuy $275.00High
ADMA Biologics stock logo
ADMA
ADMA Biologics
8/12/2019Downgraded byDawson JamesAnalyst J. KolbertBuy -> Neutral $4.00High
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
7/24/2019Initiated byDawson JamesAnalyst J. KolbertBuy $16.00Low
Adamis Pharmaceuticals stock logo
ADMP
Adamis Pharmaceuticals
7/2/2019Initiated byDawson JamesAnalyst Jason KolbertBuyMedium
inTEST stock logo
INTT
inTEST
12/28/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
Orgenesis stock logo
ORGS
Orgenesis
12/20/2018Reiterated byDawson JamesAnalyst C. WertherBuyHigh
SilverSun Technologies stock logo
SSNT
SilverSun Technologies
12/19/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
Brainstorm Cell Therapeutics stock logo
BCLI
Brainstorm Cell Therapeutics
12/18/2018Reiterated byDawson JamesAnalyst J. KolbertBuyHigh
Orgenesis stock logo
ORGS
Orgenesis
12/20/2018Initiated byDawson JamesBuy -> BuyMedium
GSE Systems stock logo
GVP
GSE Systems
12/18/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
WidePoint stock logo
WYY
WidePoint
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
Wireless Telecom Group stock logo
WTT
Wireless Telecom Group
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyLow
Cinedigm stock logo
CIDM
Cinedigm
10/22/2018Initiated byDawson JamesAnalyst B. SineBuyLow
Fennec Pharmaceuticals stock logo
FRX
Fennec Pharmaceuticals
10/10/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/A
Fennec Pharmaceuticals stock logo
FENC
Fennec Pharmaceuticals
10/11/2018Initiated byDawson JamesAnalyst C. WertherBuyHigh
Biocept stock logo
BIOC
Biocept
10/3/2018Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
Luna Innovations stock logo
LUNA
Luna Innovations
10/2/2018Initiated byDawson JamesAnalyst B. SineBuyLow
STRATA Skin Sciences stock logo
SSKN
STRATA Skin Sciences
9/4/2018Initiated byDawson JamesAnalyst R. WassermanBuyHigh
Veru stock logo
VERU
Veru
6/25/2018Reiterated byDawson JamesAnalyst R. WassermanBuyMedium
IMV stock logo
IMV
IMV
6/19/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/A
LiveOne stock logo
LVO
LiveOne
6/4/2018Reiterated byDawson JamesAnalyst B. SineBuyMedium
LiveOne stock logo
LVO
LiveOne
6/4/2018Reiterated byDawson JamesAnalyst B. SineBuyMedium
Altimmune stock logo
ALT
Altimmune
5/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
Acasti Pharma stock logo
ACST
Acasti Pharma
1/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyLow
CEL-SCI stock logo
CVM
CEL-SCI
10/16/2017Reiterated byDawson JamesAnalyst R. WassermanNeutralN/A
PAVmed stock logo
PAVM
PAVmed
9/5/2017Reiterated byDawson JamesAnalyst R. WassermanBuy $10.10High
Tonix Pharmaceuticals stock logo
TNXP
Tonix Pharmaceuticals
8/23/2017Reiterated byDawson JamesAnalyst R. WassermanBuy $18,000.00Medium
ESSA Pharma stock logo
EPIX
ESSA Pharma
8/3/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
Onconova Therapeutics stock logo
ONTX
Onconova Therapeutics
7/25/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
CEL-SCI stock logo
CVM
CEL-SCI
3/11/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/A
Enzo Biochem stock logo
ENZ
Enzo Biochem
2/9/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/A
Soleno Therapeutics stock logo
SLNO
Soleno Therapeutics
5/6/2015Initiated byDawson JamesBuy $952.50N/A
CEL-SCI stock logo
CVM
CEL-SCI
3/2/2015Initiated byDawson JamesBuy $3.00N/A
AxoGen stock logo
AXGN
AxoGen
5/14/2014Initiated byDawson JamesBuy $5.00N/A
NeoGenomics stock logo
NEO
NeoGenomics
5/14/2014Initiated byDawson JamesBuy $6.00N/A
Agenus stock logo
AGEN
Agenus
3/12/2013Reiterated byDawson JamesBuyN/A
Pediatrix Medical Group stock logo
MD
Pediatrix Medical Group
3/12/2013Downgraded byDawson JamesBuy -> Neutral $80.00N/A
Arrowhead Pharmaceuticals stock logo
ARWR
Arrowhead Pharmaceuticals
2/26/2013Initiated byDawson JamesBuy $4.00N/A
Atossa Therapeutics stock logo
ATOS
Atossa Therapeutics
12/20/2012Initiated byDawson JamesOutperform $120.00N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
12/12/2012Reiterated byDawson JamesMarket Outperform $51.00N/A
Amgen stock logo
AMGN
Amgen
12/7/2012Initiated byDawson JamesOutperform $91.00N/A
The GEO Group stock logo
GEO
The GEO Group
12/4/2012Downgraded byDawson JamesMarket PerformN/A
Spectrum Pharmaceuticals stock logo
SPPI
Spectrum Pharmaceuticals
11/27/2012Initiated byDawson JamesOutperform $15.00N/A
Sarepta Therapeutics stock logo
SRPT
Sarepta Therapeutics
11/27/2012Initiated byDawson JamesOutperformN/A
Rockwell Medical stock logo
RMTI
Rockwell Medical
11/27/2012Initiated byDawson JamesOutperform $132.00N/A
Agenus stock logo
AGEN
Agenus
11/27/2012Initiated byDawson JamesOutperformN/A
SELLAS Life Sciences Group stock logo
SLS
SELLAS Life Sciences Group
11/27/2012Initiated byDawson JamesOutperform $150.00N/A
Cytokinetics stock logo
CYTK
Cytokinetics
11/27/2012Downgraded byDawson JamesOutperformN/A
Galectin Therapeutics stock logo
GALT
Galectin Therapeutics
7/6/2012Target Lowered byDawson JamesBuy $3.00N/A
Tonix Pharmaceuticals stock logo
TNXP
Tonix Pharmaceuticals
4/26/2012Initiated byDawson JamesBuy $8,000.00N/A
Netflix stock logo
NFLX
Netflix
10/28/2011Target Lowered byDawson JamesSell$16.50 -> $7.14N/A

MarketBeat Community Rating for Dawson James

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  20,204 (Vote Outperform)
Underperform Votes:  16,831 (Vote Underperform)
Total Votes:  37,035
MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

My Account -